Minimal residual disease (MRD) detection is crucial in lymphoma management as it predicts relapse risk and guides therapeutic decisions. Traditional MRD methods often involve invasive biopsies, leading to patient https://nicolasozkh433796.wikitelevisions.com/8276595/liquid_biopsy_for_minimal_residual_disease_detection_in_lymphoma